Cargando…
SARS-CoV-2 3CL-protease inhibitors derived from ML300: investigation of P1 and replacements of the 1,2,3-benzotriazole
Starting from compound 5 (CCF0058981), a structure-based optimization of the P1 subsite was performed against the severe acute respiratory syndrome coronavirus (SARS-CoV-2) main protease (3CL(pro)). Inhibitor 5 and the compounds disclosed bind to 3CL(pro) using a non-covalent mode of action that uti...
Autores principales: | Hooper, Alice, Macdonald, Jonathan D., Reilly, Brenna, Maw, Joshua, Wirrick, Aidan P, Han, Sang Hoon, Lindsey, A. Abigail, Rico, Emma G, Romigh, Todd, Goins, Christopher M, Wang, Nancy S, Stauffer, Shaun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197776/ https://www.ncbi.nlm.nih.gov/pubmed/37214977 http://dx.doi.org/10.21203/rs.3.rs-2880312/v1 |
Ejemplares similares
-
1-Chloro-1H-1,2,3-benzotriazole
por: Yuan, Ming-Yong, et al.
Publicado: (2012) -
1-Chloromethyl-1H-1,2,3-benzotriazole
por: Zhu, Xue-wen, et al.
Publicado: (2010) -
1-Methanesulfonyl-1H-1,2,3-benzotriazole
por: Štěpnička, Petr, et al.
Publicado: (2010) -
(1H-1,2,3-Benzotriazol-1-yl)methyl benzoate
por: Guo, Ting, et al.
Publicado: (2012) -
N-(1H-1,2,3-Benzotriazol-1-ylmethyl)phthalimide
por: Wang, Su-Qing, et al.
Publicado: (2008)